CN EN
Home
Products
iPSC Cell Products

Healthy Donor-Derived iPSCs

Disease Model iPSCs

Fluorescently Labeled iPSCs (GFP/mCherry)

NGN2-Stable iPSCs

iPSC-derived Cells

iPSC-Derived Cardiomyocytes

iPSC-Derived Forebrain Neural Progenitor Cells

iPSC-Derived Mesenchymal Stromal Cells

iPSC-Derived Endothelial Cells

iPSC-Derived Renal Podocytes

iPSC-Derived Adipocytes

iPSC Culture Reagents

3D Differentiation Additives

Recombinant Human Vitronectin

UniZyme Digest

Ready-to-use CEPT

Gentlease Digestive Solution

iPSC Maintenance Medium

EDTA Digestive Solution

Stem Cell Coating Solution

Cell Differentiation Coating Solution

Neuronal Cell Coating Solution

Y27632

iPSC Cell Differentiation Kits

Cardiomyocyte Differentiation Kit

Forebrain Neuron Differentiation Kit

NGN2-mediated Neuron Differentiation Kit

Renal Podocyte Differentiation Kit

iMSC Differentiation Kit

Endothelial Cell Differentiation Kit

Adipocyte Differentiation Kit

Three Germ Layer Differentiation Kit

iPSC Organoid Differentiation Kits

Cardiac Organoid Differentiation Kit

Brain Organoid Kit

Renal Organoid Differentiation Kit

Services
iPSC Line Generation and Characterization iPSC Gene Editing iPSC Cell Differentiation iPSC Organoid Differentiation
News & Event
Information Lookup
About Us
86-400-8228-027
Cn En
Phone
Phone：+86-400-8228-027
WeChat
Contact Us
We offer a multi-channel service platform to provide you with greater convenience
Manual Videos Q&A References
References
03
2026-02
Generation of an integration-free induced pluripotent stem cell line (LZUSHI001-A) from an epileptic patient with DGKG mutation.
03
2026-02
Generation of a gene corrected human isogenic iPSC line (CPGHi001-A-1) from a hearing loss patient with the TMC1 p.M418K mutation using CRISPR/Cas9.
03
2026-02
Synergistic effects of a combined treatment of PI3K/mTOR dual inhibitor LY3023414 and carboplatin on human endometrial carcinoma.
03
2026-02
CRISPR/Cas9 mediated generation of a iPSC line EHTJUi005-A-1 with homozygous knockout of the SUV39H1 gene.
03
2026-02
Generation of an induced pluripotent stem cell line (FDCHI007-A) derived from a patient with Developmental and epileptic encephalopathy Type 31 carrying heterozygous c.545 C>A mutation in DNM1 gene.
03
2026-02
ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrom.
03
2026-02
Functional analysis of HECA variants identified in congenital heart disease in the Chinese populati
03
2026-02
Generation of an induced pluripotent stem cell line (FDCHi008-A) from an infant with chronic intestinal pseudo-obstruction
03
2026-02
Biallelic MED16 variants disrupt neural development and lead to an intellectual disability syndrome
27
2026-01
A novel mechanism involving USP53-regulated BSEP trafficking underlies low-GGT intrahepatic cholestasis
27
2026-01
Sitosterolemia with Orbital Xanthogranulomas
We are committed to providing research institutions, pharmaceutical companies, and clinical translation research with one-stop iPSC-related technologies, products, and solutions.
iPSC Product

iPSC Cell Products

iPSC-derived Cells

iPSC Culture Reagents

iPSC Cell Differentiation Kits

iPSC Organoid Differentiation Kits

iPSC Service

iPSC Line Generation and Characterization

iPSC Gene Editing

iPSC Cell Differentiation

iPSC Organoid Differentiation

Quick Links

Home

Products

Services

About Us

Information Lookup

Contact Us

Contact Us

Building 28, No. 18, Lane 99, Chun Guang Road, Minhang District, Shanghai, China

+86-400-8228-027

soma@somaxbio.com

© 2026 Soma Biotechnology (Shanghai) Co., Ltd. All rights reserved.沪ICP备2026003108号沪公网安备31011202022106号